Skip to main content

Centiva Capital, LP

Position in GRAL — GRAIL, Inc.

CIK 1692507 New York, NY

Position in GRAL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$56,322
+$4,953 QoQ
Shares Held
825
-17.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#235
of 374 holders
Holding Since
Sep 2024
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Jun 30, 2026
CallValue
$3,413,500
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Centiva Capital, LP holds $3,725,083 across 4 Diagnostics & Research names. GRAL ranks #4 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 GRAL
GRAIL, Inc.
This page
825 $56,322

All Filings in GRAL

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,322 825
2026-06-30 $3,413,500 50,000
2026-03-31 $51,369 994
2026-03-31 $2,584,000 50,000
2024-09-30 $143,104 10,400